Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China

被引:14
|
作者
An, Shuo-yan [1 ,2 ]
Yang, Yin-jian [1 ,2 ]
Hang, Fei [1 ,2 ]
Wang, Zhi-min [2 ,3 ]
Fan, Chao-mei [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Key Lab Clin Trial Res Cardiovasc Drugs, Minist Hlth, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Ultrasound, Beijing, Peoples R China
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
TASK-FORCE; FOLLOW-UP; MYECTOMY; SURVIVAL; METAANALYSIS; GUIDELINE; DIAGNOSIS; DEATH; YOUNG;
D O I
10.1038/s41598-017-10144-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on procedural complications and long term survival after alcohol septal ablation (ASA) in Chinese patients with obstructive hypertrophic cardiomyopathy (HOCM) are lacking. We aimed to investigate long-term survival of HOCM patients after ASA and compared to the non-obstructive hypertrophic cardiomyopathy(NOHCM). A total of 233 patients with HOCM and a peak pressure gradient of >= 50 mm Hg at rest or with provocation were consecutively enrolled from Fuwai Hospital in China between 2000 and 2012. Another 297 patients without left ventricular outflow tract obstruction were regarded as control group. Periprocedural mortality of ASA were low (0.89%). Periprocedural lethal ventricular arrhythmia occurred in 9 patients (4.0%). Alcohol volume (RR 1.44, 95% CI: 1.03-2.03, P = 0.034) and age <= 40 years old (RR 4.63, 95% CI: 1.07-20.0, P = 0.040) were independent predictors for periprocedural lethal ventricular arrhythmia. The 10-year overall survival was 94.6% in the ASA group, similar with 92.9% in the NOHCM group (P = 0.930). In conclusion, periprocedural mortality and complications were rare in ASA. Long term survival after ASA were satisfactory and comparable to NOHCM. Patients under 40 years old should be more cautious undergoing ASA, for these patients were more likely to endure lethal ventricular arrhythmia during periprocedural period of ASA.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Indications, Technical Aspects, and Clinical Outcomes
    Spaziano, Marco
    Sawaya, Fadi J.
    Lefevre, Thierry
    JOURNAL OF INVASIVE CARDIOLOGY, 2017, 29 (12) : 404 - 410
  • [22] Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Technical review and long-term clinical and echocardiographic outcomes
    Leal, Silvio
    Galeote, Guillermo
    Jimenez-Valero, Santiago
    Sanchez-Recalde, Angel
    Salinas, Pablo
    Saez Ruiz, Alejandro
    Calvo Orbe, Luis
    Dominguez, Francisco
    Moreno, Raul
    Luis Lopez-Sendon, Jose
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 (05) : 363 - 371
  • [23] Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis
    Veselka, Josef
    Faber, Lothar
    Liebregts, Max
    Cooper, Robert
    Januska, Jaroslav
    Kashtanov, Maksim
    Dabrowski, Maciej
    Hansen, Peter Riis
    Seggewiss, Hubert
    Hansvenclova, Eva
    Bundgaard, Henning
    ten Berg, Jurrien
    Stables, Rodney Hilton
    Jensen, Morten Kvistholm
    EUROPEAN HEART JOURNAL, 2019, 40 (21) : 1681 - 1687
  • [24] Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
    Scholtz, Smita
    Rudolph, Volker
    Reil, Jan-Christian
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [25] Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy
    Veselka, Josef
    Faber, Lothar
    Liebregts, Max
    Cooper, Robert
    Januska, Jaroslav
    Kashtanov, Maksim
    Dabrowski, Maciej
    Hansen, Peter Riis
    Seggewiss, Hubert
    Bonaventura, Jiri
    Polakova, Eva
    Hansvenclova, Eva
    Bundgaard, Henning
    ten Berg, Jurrien
    Stables, Rodney Hilton
    Jarkovsky, Jiri
    Jensen, Morten Kvistholm
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 333 : 127 - 132
  • [26] Alcohol Septal Ablation in a Patient With Hypertrophic Obstructive Cardiomyopathy
    Agarwal, Shvetank
    Puri, Suvikram
    Wang, Hong
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2014, 28 (02) : 350 - 354
  • [27] Myectomy versus alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
    Afanasyev, Alexander, V
    Bogachev-Prokophiev, Alexander, V
    Kashtanov, Maxim G.
    Astapov, Dmitriy A.
    Zalesov, Anton S.
    Budagaev, Sergei A.
    Sharifulin, Ravil M.
    Idov, Eduard M.
    Zheleznev, Sergei, I
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2020, 31 (02) : 158 - 165
  • [28] Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
    Sorajja, Paul
    Ommen, Steve R.
    Holmes, David R., Jr.
    Dearani, Joseph A.
    Rihal, Charanjit S.
    Gersh, Bernard J.
    Lennon, Ryan J.
    Nishimura, Rick A.
    CIRCULATION, 2012, 126 (20) : 2374 - 2380
  • [29] Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
    Gragnano, Felice
    Pelliccia, Francesco
    Guarnaccia, Natale
    Niccoli, Giampaolo
    De Rosa, Salvatore
    Piccolo, Raffaele
    Moscarella, Elisabetta
    Fabris, Enrico
    Montone, Rocco Antonio
    Cesaro, Arturo
    Porto, Italo
    Indolfi, Ciro
    Sinagra, Gianfranco
    Perrone Filardi, Pasquale
    Ando, Giuseppe
    Calabro, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (08)
  • [30] Patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation have favorable long-term outcome irrespective of their genetic background
    Bonaventura, Jiri
    Norambuena, Patricia
    Votypka, Pavel
    Hnatova, Hana
    Adlova, Radka
    Macek, Milan, Jr.
    Veselka, Josef
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2020, 10 (02) : 193 - +